DD
EW icon

Dominick & Dominick’s Edwards Lifesciences EW Stock Holding History

Dominick & Dominick’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-29,400
Closed -$363K – 187
2014
Q1 		$363K Hold
29,400
– – 0.18% 125
2013
Q4 		$322K Buy
+29,400
New +$331K 0.15% 141

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dominick & Dominick's EW Position: Q2 2014 in Review

Dominick & Dominick sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 29,400 shares — an estimated $363K sold.

Dominick & Dominick first reported a position in EW in Q4 2013 and held it in 2 quarters. The position peaked at $363K in Q1 2014. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Dominick & Dominick reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
  • Dominick & Dominick sold 29,400 Edwards Lifesciences shares in Q2 2014, an estimated $363K.
  • Dominick & Dominick first reported a position in Edwards Lifesciences in Q4 2013 and held it in 2 quarters.
  • Dominick & Dominick's Edwards Lifesciences position peaked at $363K in Q1 2014.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Dominick & Dominick's 13F filing for Q2 2014, filed 12 Aug 2014.